Aspire Growth Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$685K Sell
2,698
-44
-2% -$10.3K 0.4% 53
2026
Q1
$670K Sell
2,742
-246
-8% -$57.3K 0.46% 51
2025
Q4
$618K Sell
2,988
-321
-10% -$63.5K 0.43% 51
2025
Q3
$614K Buy
3,309
+12
+0.4% +$2.06K 0.45% 52
2025
Q2
$504K Sell
3,297
-18
-0.5% -$2.77K 0.41% 58
2025
Q1
$521K Sell
3,315
-246
-7% -$38.5K 0.46% 57
2024
Q4
$515K Buy
+3,561
New +$552K 0.5% 53

Other funds holding JNJ

Aspire Growth Partners's JNJ Position: Q2 2026 in Review

Aspire Growth Partners reduced its Johnson & Johnson (JNJ) stake by 1.6% in Q2 2026, selling an estimated $10.3K and leaving 2,698 shares worth $685K. The position accounts for 0.4% of the portfolio, ranked #53.

Aspire Growth Partners first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. 4,678 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Aspire Growth Partners held 2,698 shares of Johnson & Johnson worth $685K as of Q2 2026.
  • Aspire Growth Partners sold 44 Johnson & Johnson shares in Q2 2026, an estimated $10.3K.
  • Johnson & Johnson made up 0.4% of Aspire Growth Partners's portfolio in Q2 2026, its #53 holding.
  • Aspire Growth Partners first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • 4,678 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Aspire Growth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.